/
Natural Products Chemistry Natural Products Chemistry

Natural Products Chemistry - PowerPoint Presentation

olivia-moreira
olivia-moreira . @olivia-moreira
Follow
350 views
Uploaded On 2018-10-26

Natural Products Chemistry - PPT Presentation

Featuring conus magus Who is Conus Magus Conus Magus is one of approximately 700 species of cone snails Cone snails are indigenous to coral reefs in the IndoPacific regions of southern Asia and northern Australia They can also be found in the Mediterranean and Hawaii ID: 697706

snail cone conotoxins conotoxin cone snail conotoxin conotoxins venom conus prialt channels snails pain toxins species calcium ion volume

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Natural Products Chemistry" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Natural Products Chemistry

Featuring

conus

magusSlide2

Who is

Conus

Magus?

Conus

Magus is one of approximately 700 species of cone snails. Cone snails are indigenous to coral reefs in the Indo-Pacific regions of southern Asia and northern Australia. They can also be found in the Mediterranean and Hawaii. Slide3

Cone snails are

CARNIVORES

,

and each cone snail contains a cocktail of approximately

200 different toxins

-more than any other creature- which is used to incapacitate their prey.

Cone snails range in size from four to six inches long and have varying colors and patterned shells.

Mmm

this leaf is delicious

Like normal snails, cone snails are slow-moving, depending mainly on their protective exterior for defense from predators.

Ordinary Garden Snail:Slide4

What?! A Killer Snail?! How?Slide5

The cone snail’s harpoon fires with enough force to pierce through a 3 mm wetsuit. Although many species’ stings are no worse than that of a bee, stings from some of the larger species can lead to

paralysis

,

respiratory failure

, and

death

. There is no known anti-venom.

Being stung by a cone snail “is like being bitten by a cobra and eating

fugu

at the same time.” (BALDOMERA OLIVERA, PHD) Note: The

fugu’s

toxin is more than a thousand times deadlier to humans than cyanide.Slide6

“Eddie Carr: I loaded the enhanced venom of

Conus

purpurascens, the South Sea cone snail. Most powerful neurotoxin in the world. Acts within a two-thousandth of a second. Faster than the nerve-conduction velocity. The animal's down before it feels the prick of the dart.

Ian Malcolm: Is there an antidote? Eddie Carr: What, like if you shot yourself in the foot? Don't do that. You'd be dead before you realized you'd had an accident. “In Jurassic Park 2, cone snail venom was used as a weapon strong enough to take down a tyrannosaurus

rex

.Slide7

Cone snail venom, called

conotoxin

, is a mixture developed in a special gland and delivered to the hollow harpoon, which contains approximately

200 different toxins

. Slide8

Each species of cone snail produces it’s own cocktail of toxins, and there is no overlap of

toxins between species

at all

.

700 species x 200 toxins=

140,000 compoundsSlide9

How does one collect

lethal mollusk venom

?

Cone snails can be “milked” in the laboratory, often using fish fins for bait attached to a non-lubricated condom in which the venom can be collected and then analyzed.Slide10

Chemically

conotoxins

are made up of

small

peptides, 10 to 30 amino acid residues in length, which target ion receptors and channels in the neuromuscular system.

Less than

1%

of these

cono

-peptides have been pharmacologically characterized. However, several are currently in the process of undergoing clinical trials and many more are being investigated for varying uses.Slide11

Conopeptides

being developed for pain treatment:Slide12

Individual peptides are separated out via High Performance Liquid Chromatography (

HPLC

), which provides a chromatogram of the different components. This allows us to isolate a pure peptide and determine it’s amino acid sequence, as well as to determine the effects of each individual

conotoxin

. Each peak represents a different peptide, with a different absorbance value.Slide13

This is a chromatogram from one cone snail (

conus

geographus

) which shows the varying effects of choice peptides that were isolated from this mixture (on mice).Slide14

This particular peptide was isolated from the

conotoxin

of

Conus

Magus. It’s synthetic form, ziconotide, was used to create the first FDA approved analgesic via the cone snail, marketed as “Prialt

,” in 2004.

Prialt

is

1,000

times more potent than morphine, at lower doses, yet is without morphine’s addictive properties.Slide15

In fish, this

conotoxin

targets ion channels between the

muscles

and the brain, blocking the transmission of signals which leads to flaccid paralysis.

However, in the human body, these particular ion channels are resistant to

prialt

, even at high concentrations. Instead,

prialt

is effective on ion channels in

pain fibers

.Slide16

Prialt

lodges in the calcium channels, blocking the calcium from entering the cell. The Fiber continues to fire, but the signal is not transmitted to nerve so the brain does not receive it. Therefore, we do not perceive the pain.

How does

Prialt

work as a pain killer?Electrical signals sent along the pain fibers cause calcium channels to open

Calcium passes through the ion channels, triggering a release of neurotransmitters

Neurotransmitters communicate with nerves which signal pain to the brain

PRIALTSlide17

High Affinity

+

Narrow Specificity

Side effects of many drugs are caused by drug binding not only to the target receptor with therapeutic value, but also to other receptors which may cause undesirable responses.

In contrast, conotoxins can discriminate among closely related receptor sub-types. The omega-conotoxin used in prialt

binds only to a specific subtype of calcium channels in neuronal tissue, and excludes those in skeletal or cardiac muscle, with a discrimination ratio up to

100,000,000

.Slide18

Dizziness (47%), Nausea

(41%), Confusion (18-33%),

Weakness (22%), Speech

Disorder (9-14%), Muscle Spasms (16%), Drowsiness (22%), Memory Impairment (7-22%), Diarrhea (19%), Vomiting (16%), Headache (15%), Abnormal Gait (15%), Headache (13%), Aphasia (8-12%), Hallucinations (12%), Blurred Vision (12%)

Side Effects:Slide19

Alpha-

conotoxins

investigated for blocking of nicotinic acetylcholine receptors, which aids in overcoming nicotine addiction.

Potential Uses for

Conotoxins:

Alpha-

Conotoxin

ACV1

in phase II clinical trials developed for treatment of sciatica, shingles, and diabetic neuropathy. This specific

conotoxin

also has potential for accelerating the functional recovery of injured nerves and tissues.Slide20

Alpha- and kappa-

conotoxins

investigated for treating

neuroprotection

, schizophrenia, depression, and cancer.Potential Uses for Conotoxins:

Other

conotoxins

show prospects for being potent pharmaceuticals in the treatment of Alzheimer’s disease, Parkinson’s disease, and epilepsy.Slide21

QUESTIONS

?Slide22

Newman, D.J.,

Cragg

, G.M. (2007).

Natural Products as Sources of New Drugs over the Last 25 Years. Journal of Natural Products, Volume 70 (3)

, 461-477.Dobson, R., Collodoro, M., et al. (2012). Secretion and maturation of conotoxins in the venom ducts of

Conus

textile

.

Toxicon

, Volume 60 (8),

1370-1379.

Olivera

, B.M.,

Rivier

J., et al. (1990).

Diversity of

Conus

Neuropeptides. Science, Volume 249 (4966),257-263.Olivera

, B.M. (2009), From Venom to Drugs, HHMI Holiday Lectures on Science

, Lecture conducted from Howard Hughes Medical Institute, Chevy Chase, Maryland. http://media.hhmi.org/hl/09Lect1.html

References:Slide23

Fan, Y., Song, J., et al. (2011)

PREDCSF: An integrated feature-based approach for predicting

conotoxin

superfamily

. Peptide and protein letters, volume 18 (3), 261-267. Kirtan, D., Lahiry, A., (2012) Conotoxins

: review and docking studies to determine potentials of

conotoxin

as anticancer drug molecule

,

Current topics in medicinal chemistry, volume 12 (8)

, 845-851.

References: